Robert Malone on covid: what the evidence says · JRE #1757
SUBJECT: COVID
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
What they did with that was a very small study with intrinsic bias all over the place, much, much smaller than the Israeli study that you're citing, much less rigorous, less statistical power
What the evidence says 01 / RECORD
The CDC study Malone references is a 2021 MMWR case-control analysis from Kentucky (Cavanaugh et al.) that matched 246 reinfected case-patients with 492 controls (738 total) and found unvaccinated previously-infected residents had 2.34 times the odds of reinfection versus fully vaccinated previously-infected residents (95% CI, 1.58-3.47). The Israeli study commonly cited in this debate (Gazit et al., published in Clinical Infectious Diseases, 2022) analyzed a much larger cohort of 124,500 people and found naturally acquired immunity conferred stronger protection against Delta-variant infection and symptomatic disease than two-dose BNT162b2 vaccination. Malone's characterization of the size difference is accurate: the Kentucky study's sample (738) is roughly 170 times smaller than the Israeli cohort (124,500), a genuine statistical-power disparity, and the Israeli study's confidence intervals are comparatively tighter. However, his framing implies the CDC finding should be dismissed as an outlier; in fact several other CDC and peer-reviewed studies from the same period independently found that vaccination added measurable protection on top of prior infection, so the evidence across studies is mixed rather than resolved in favor of natural immunity alone. Neither study has been retracted.